Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system
- 5 September 2007
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 342 (1-2), 72-77
- https://doi.org/10.1016/j.ijpharm.2007.04.034
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Supercritical fluid assisted impregnation of indomethacin into chitosan thermosets for controlled release applicationsInternational Journal of Pharmaceutics, 2006
- Poly Lactic Acid Based Injectable Delivery Systems for Controlled Release of a Model Protein, LysozymePharmaceutical Development and Technology, 2006
- Applications of injectable polymeric implants for protein and DNA deliveryIsrael Journal of Chemistry, 2005
- Controlled delivery of testosterone from smart polymer solution based systems: In vitro evaluationInternational Journal of Pharmaceutics, 2005
- In Vitro Release of Levonorgestrel from Phase Sensitive and Thermosensitive Smart Polymer Delivery SystemsPharmaceutical Development and Technology, 2005
- Structure formation in injectable poly(lactide–co-glycolide) depotsJournal of Controlled Release, 2003
- Sustained activity and release of leuprolide acetate from an in situ forming polymeric implantAAPS PharmSciTech, 2000
- End Group Effects on Surface Properties of Polymers: Semiempirical Calculations and Comparison to Experimental Surface Tensions for α,ω-Functional Poly(dimethylsiloxanes)Macromolecules, 1997
- Correction of Perfusate Concentration for Sample RemovalJournal of Pharmaceutical Sciences, 1982
- The measurement of lysozyme activity and the ultra-violet inactivation of lysozymeBiochimica et Biophysica Acta, 1952